EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthetic O‐Polysaccharide Backbone Units for a Single Antigen Vaccine Against Two Major Non‐Typhoidal Salmonella Serovars

Xingling Pan, Changxin Huo, Soham Maity, Herbert Kavunja, Rachel Moszyk, Cameron Talbot, Scott M. Baliban, Xuefei Huang

Angewandte Chemie · 22.06.2026 · 138 (26)

DOI: 10.1002/ange.7740689 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie, online erschienen am 07.05.2026. Verfasst von Xingling Pan und 7 weiteren Autor:innen. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Allergy and Infectious Diseases.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Salmonella infections can cause life‐threatening systemic diseases in many regions of the world. With the prevalence of antimicrobial‐resistant Salmonella , vaccines are urgently needed to prevent and reduce infections. There are no vaccines available against any non‐typhoidal Salmonella (NTS) serovars, including two of the most common ones, that are, Salmonella Typhimurium and Salmonella Enteritidis. While traditional Salmonella vaccine approaches require a construct against each serotype, a new strategy has been developed in this work targeting the shared O‐polysaccharide backbone as a potential common vaccine antigen. Tri‐, hexa‐, and nona‐saccharides corresponding to one to three repeating units of the O‐polysaccharide backbone were synthesized stereoselectively via a modular approach. These oligosaccharides were conjugated to the bacteriophage Qβ carrier, which elicited strong IgG responses against the synthetic carbohydrate antigens upon immunization of both mice and rabbits. The trisaccharide antigen was sufficient to induce protective antibodies. The post‐immune sera from Qβ‐trisaccharide immunized rabbits recognized the native O‐polysaccharides from both S . Typhimurium and S . Enteritidis, and significantly protected mice against lethal challenges by these Salmonella serotypes. The ability of a single glycan antigen to protect against infections by two different NTS serovars is a significant step forward for broad‐spectrum anti‐ Salmonella vaccine design.

Förderung

  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Pan, X., Huo, C., Maity, S., Kavunja, H., Moszyk, R., Talbot, C., Baliban, S. M., & Huang, X. (2026). Synthetic O‐Polysaccharide Backbone Units for a Single Antigen Vaccine Against Two Major Non‐Typhoidal Salmonella Serovars. Angewandte Chemie, 138(26). https://doi.org/10.1002/ange.7740689

Vancouver

Pan X, Huo C, Maity S, Kavunja H, Moszyk R, Talbot C, et al. Synthetic O‐Polysaccharide Backbone Units for a Single Antigen Vaccine Against Two Major Non‐Typhoidal Salmonella Serovars. Angewandte Chemie. 2026;138(26). doi:10.1002/ange.7740689

BibTeX
@article{Pan2026,
  author = {Pan, Xingling and Huo, Changxin and Maity, Soham and Kavunja, Herbert and Moszyk, Rachel and Talbot, Cameron and Baliban, Scott M. and Huang, Xuefei},
  title = {Synthetic O‐Polysaccharide Backbone Units for a Single Antigen Vaccine Against Two Major Non‐Typhoidal Salmonella Serovars},
  journal = {Angewandte Chemie},
  year = {2026},
  volume = {138},
  number = {26},
  doi = {10.1002/ange.7740689}
}
Kostenlos starten →